Market Tracker

01/18 4:45am ET

Emergent BioSolutions Inc (NYSE:EBS)

30.00
Delayed Data
As of Jan 17
 -0.66 / -2.15%
Today’s Change
24.47
Today|||52-Week Range
41.91
-8.65%
Year-to-Date

Today’s Trading

Previous close30.66
Today’s open30.68
Day’s range29.44 - 30.68
Volume577,222
Average volume (3 months)502,672
Market cap$1.2B
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-51.06%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+16.14%
P/E ratio30.6
Price/Sales3.62
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-1.30-5.18%
INVAInnoviva Inc-0.47-4.14%
SGYPSynergy Pharmaceutic...-0.25-3.71%
AXONAxovant Sciences Ltd-0.65-5.02%
Data as of 01/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)$0.39
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts